Shandong Weigao Orthopedic Device Co., Ltd. signed an asset purchase agreement to acquire Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. (SZSE:002492) in a reverse merger transaction on June 14, 2016. Under the terms of the agreement, Zhuhai Winbase International Chemical Tank Terminal Co., Ltd will issue 479.8 million shares Shandong Weigao Orthopedic Device Co., Ltd. along with minority shareholders and transfer all of the assets to Shandong Weigao Group Logistic Company Limited. The deal is subject to approval by shareholders of Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. and Shandong Weigao Orthopedic Device Co., Ltd., approval of Board of Directors of Zhuhai Winbase International Chemical Tank Terminal Co., Ltd, stock exchange approval and approval by Chinese authorities including China Securities Regulatory Commission.

The transaction is subject to approvals from authorized Ministry of Commerce departments on the foreign-investment matters involved in the transaction. The meeting of shareholders of Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. will be held on June 30, 2016. The Board of Zhuhai Winbase International Chemical Tank Terminal Co., Ltd and Shandong Weigao Group Medical Polymer Company Limited approved the transaction on June 14, 2016.

The stock exchange approved the transaction on July 13, 2016. GF Securities Co., Ltd. acted as the financial advisor and Zhong Lun Law Firm acted as the legal advisor to Zhuhai Winbase International Chemical Tank Terminal Co., Ltd. Deloitte Touche Tohmatsu Certified Public Accountants LLP acted as the auditor and Beijing China Alliance Appraisal Co., Ltd acted as the appraiser in the transaction.